While Warburg Pincus is close to acquiring a 49 per cent stake in CAMS, Malaysia’s Maxis is planning to invest at least $500 million more in Aircel. Also, Indian drug manufacturers Aurobindo Pharma and Dr Reddy’s Laboratories Ltd are the frontrunners to acquire Orchid Pharma.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
